|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 263.28 USD | +0.87% |
|
-1.34% | +28.08% |
| 11-29 | STERIS plc acquired Medik Hospital Design GmbH. | CI |
| 11-25 | Steris Insider Sold Shares Worth $1,312,096, According to a Recent SEC Filing | MT |
| Capitalization | 25.62B 22.02B 20.63B 19.23B 35.51B 2,306B 38.63B 241B 93.17B 1,089B 96.15B 94.1B 3,982B | P/E ratio 2026 * |
32.1x | P/E ratio 2027 * | 28.4x |
|---|---|---|---|---|---|
| Enterprise value | 26.85B 23.08B 21.62B 20.15B 37.23B 2,417B 40.49B 253B 97.66B 1,141B 101B 98.63B 4,173B | EV / Sales 2026 * |
4.53x | EV / Sales 2027 * | 4.16x |
| Free-Float |
98.99% | Yield 2026 * |
0.94% | Yield 2027 * | 1.02% |
Last Transcript: STERIS plc
| 1 day | +0.87% | ||
| 1 week | -1.34% | ||
| Current month | -1.13% | ||
| 1 month | +8.86% | ||
| 3 months | +8.17% | ||
| 6 months | +8.75% | ||
| Current year | +28.08% |
| 1 week | 256.68 | 266.7 | |
| 1 month | 247 | 268.6 | |
| Current year | 200.98 | 268.6 | |
| 1 year | 200.98 | 268.6 | |
| 3 years | 173.21 | 268.6 | |
| 5 years | 159.21 | 268.6 | |
| 10 years | 61.38 | 268.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
Daniel Carestio
CEO | Chief Executive Officer | 52 | 28/07/2021 |
Karen Burton
DFI | Director of Finance/CFO | 58 | 17/08/2025 |
Julie Winter
IRC | Investor Relations Contact | - | 30/04/2004 |
| Director | Title | Age | Since |
|---|---|---|---|
Richard Breeden
BRD | Director/Board Member | 75 | 31/03/2008 |
Cynthia Feldmann
BRD | Director/Board Member | 72 | 28/02/2005 |
Nirav Shah
BRD | Director/Board Member | 53 | 30/04/2018 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.87% | -1.34% | +21.19% | +37.19% | 25.62B | ||
| -0.26% | -2.69% | +7.86% | +15.72% | 218B | ||
| -0.62% | -3.49% | +18.80% | +27.30% | 131B | ||
| +0.60% | -7.83% | +36.77% | +95.22% | 65.5B | ||
| +0.10% | +0.03% | -12.41% | -23.15% | 55.3B | ||
| +0.25% | +2.09% | +20.19% | +70.41% | 52.12B | ||
| +0.37% | +4.73% | -19.16% | -44.55% | 25.45B | ||
| -0.33% | +5.07% | +17.94% | -37.25% | 24.28B | ||
| -2.23% | -2.27% | -23.56% | +17.98% | 23.09B | ||
| -3.62% | -6.83% | +13.11% | -1.16% | 22.22B | ||
| Average | -0.49% | -0.77% | +8.07% | +15.77% | 64.24B | |
| Weighted average by Cap. | -0.29% | -1.95% | +11.18% | +23.24% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.92B 5.09B 4.77B 4.45B 8.21B 533B 8.93B 55.8B 21.55B 252B 22.24B 21.76B 921B | 6.29B 5.41B 5.07B 4.72B 8.72B 566B 9.49B 59.28B 22.89B 268B 23.62B 23.12B 978B |
| Net income | 799M 687M 643M 600M 1.11B 71.9B 1.2B 7.53B 2.91B 33.96B 3B 2.93B 124B | 897M 771M 723M 673M 1.24B 80.75B 1.35B 8.45B 3.26B 38.14B 3.37B 3.3B 139B |
| Net Debt | 1.23B 1.06B 994M 926M 1.71B 111B 1.86B 11.62B 4.49B 52.44B 4.63B 4.53B 192B | 581M 499M 468M 436M 805M 52.27B 876M 5.47B 2.11B 24.69B 2.18B 2.13B 90.27B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/12/25 | 263.28 $ | +0.87% | 583,537 |
| 04/12/25 | 261.02 $ | +0.62% | 537,785 |
| 03/12/25 | 259.40 $ | +0.04% | 396,349 |
| 02/12/25 | 259.30 $ | -1.37% | 571,468 |
| 01/12/25 | 262.89 $ | -1.27% | 747,183 |
Delayed Quote Nyse, December 05, 2025 at 09:00 pm
More quotesTrader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- STE Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
















